Staff turnover in EUR241,727231,784239,290234,554244,695
Staff turnover in EUR241,727231,784239,290234,554244,695
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)18.8018.8018.8070.6518.80
Dividend per share0.690.730.770.810.85
Basic earnings per share8.677.737.886.696.79
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover2,830.72,885.52,951.12,892.73,074.7
Operating income (EBIT)651.8589.7583.4500.2514.3
Earnings before taxes748.9679.9698.0585.5600.9
Annual net profit/ loss661.8585.9593.4492.7493.7
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets1,742.01,919.51,936.41,538.11,978.2
Total fixed assets1,571.81,697.31,893.12,105.32,291.8
Total assets3,313.83,616.83,829.53,643.44,270.0
Liabilities
Total short-term liabilities594.1519.0671.8550.4654.9
Total long-term liabilities384.3412.9276.7410.7439.1
Total provisions69.447.329.628.229.0
Equity capital2,335.42,684.92,881.02,682.33,176.0
Total liabilities3,313.83,616.83,829.53,643.44,270.0
Management:
Myla Lai-Goldman
Stephen Lockhart
William Feehery
Deborah Keller
Douglas Michels
Janet Haugen
Mark Buthman
Molly Joseph
Paolo Pucci
Robert Friel
Thomas Hofmann
Eric M. Green
Annette F. Favorite
Bernard J. Birkett
Cindy Reiss-Clark
Silji Abraham
Board:
Shareholding in %:
Address: 530 Herman O. West Drive, 19341-1147 Exton
T: +1-610-594-2900
F: +
I: http://www.westpharma.com
E: